| 1 | 2024 Revision of the level of evidence grading system for ESC clinical practice guideline recommendations II: diagnostic tests and prediction models | 2.2 | 10 | Citations (PDF) |
| 2 | 2024 Revision of the level of evidence grading system for ESC clinical practice guideline recommendations I: therapy and prevention | 2.2 | 24 | Citations (PDF) |
| 3 | School-based health care: improving academic outcomes for inner-city children—a prospective cohort quasi-experimental study | 2.2 | 3 | Citations (PDF) |
| 4 | Within and beyond 12-month efficacy and safety of antithrombotic strategies in patients with established coronary artery disease: two companion network meta-analyses of the 2022 joint clinical consensus statement of the European Association of Percutaneous Cardiovascular Interventions (EAPCI), European Association for Acute CardioVascular Care (ACVC), and European Association of Preventive Cardiology (EAPC) | 4.0 | 35 | Citations (PDF) |
| 5 | PRECISE-DAPT score for bleeding risk prediction in patients on dual or single antiplatelet regimens: insights from the GLOBAL LEADERS and GLASSY | 4.0 | 59 | Citations (PDF) |
| 6 | Impact of white blood cell count on clinical outcomes in patients treated with aspirin-free ticagrelor monotherapy after percutaneous coronary intervention: insights from the GLOBAL LEADERS trial | 4.0 | 13 | Citations (PDF) |
| 7 | Five-Year Outcomes With Biodegradable-Polymer Sirolimus-Eluting Stents Versus Durable-Polymer Everolimus-Eluting Stents in Patients With Acute Coronary Syndrome: A Subgroup Analysis of the BIOSCIENCE Trial | 0.7 | 5 | Citations (PDF) |
| 8 | 2021 ESC/EACTS Guidelines for the management of valvular heart disease | 2.2 | 5,033 | Citations (PDF) |
| 9 | A randomized trial comparing axillary versus innominate artery cannulation for aortic arch surgery | 2.6 | 33 | Citations (PDF) |
| 10 | Restrictive versus liberal transfusion in patients with diabetes undergoing cardiac surgery: An o
pen‐label,
randomized, blinded outcome evaluation trial | 4.5 | 8 | Citations (PDF) |
| 11 | Effect of transcutaneous electrical nerve stimulation (TENS) on knee pain and physical function in patients with symptomatic knee osteoarthritis: the ETRELKA randomized clinical trial | 5.5 | 45 | Citations (PDF) |
| 12 | Ticagrelor Monotherapy or Dual Antiplatelet Therapy After Drug‐Eluting Stent Implantation: Per‐Protocol Analysis of the GLOBAL LEADERS Trial | 4.0 | 8 | Citations (PDF) |
| 13 | Clinical Trial Design Principles and Outcomes Definitions for Device-Based Therapies for Hypertension: A Consensus Document From the Hypertension Academic Research Consortium | 18.0 | 73 | Citations (PDF) |
| 14 | Efficacy of topical progesterone versus topical clobetasol propionate in patients with vulvar Lichen sclerosus – A double-blind randomized phase II pilot study | 0.9 | 14 | Citations (PDF) |
| 15 | Identifying clinical subtypes in sepsis-survivors with different one-year outcomes: a secondary latent class analysis of the FROG-ICU cohort | 6.0 | 35 | Citations (PDF) |
| 16 | Guía ESC/EACTS 2021 sobre el diagnóstico y tratamiento de las valvulopatías | 1.1 | 37 | Citations (PDF) |
| 17 | Impact of proton pump inhibitors on efficacy of antiplatelet strategies with ticagrelor or aspirin after percutaneous coronary intervention: Insights from the GLOBAL LEADERS trial | 1.7 | 12 | Citations (PDF) |
| 18 | Is Internal Rotation Measurement of the Hip Useful for Ruling in Cam or Pincer Morphology in Asymptomatic Males? A Diagnostic Accuracy Study | 1.7 | 1 | Citations (PDF) |
| 19 | Cardiovascular meta-analyses: fool’s gold or gold for fools? | 2.2 | 2 | Citations (PDF) |
| 20 | Visual Analogue Scale has higher assay sensitivity than WOMAC pain in detecting between-group differences in treatment effects: a meta-epidemiological study | 5.5 | 73 | Citations (PDF) |
| 21 | Usefulness of updated logistic clinical SYNTAX score based on MI‐SYNTAX score in patients with ST‐elevation myocardial infarction | 1.7 | 4 | Citations (PDF) |
| 22 | Safety and Efficacy of 1-Month Dual Antiplatelet Therapy (Ticagrelor + Aspirin) Followed by 23-Month Ticagrelor Monotherapy in Patients Undergoing Staged Percutaneous Coronary Intervention (A Sub-Study from GLOBAL LEADERS) | 1.8 | 6 | Citations (PDF) |
| 23 | 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation | 2.2 | 4,346 | Citations (PDF) |
| 24 | Ticagrelor Monotherapy Versus Dual-Antiplatelet Therapy After PCI | 3.0 | 38 | Citations (PDF) |
| 25 | Predicting 2‐year all‐cause mortality after contemporary PCI: Updating the logistic clinical SYNTAX score | 1.7 | 7 | Citations (PDF) |
| 26 | Comparison of Investigator-Reported and Clinical Event Committee–Adjudicated Outcome Events in GLASSY | 4.1 | 11 | Citations (PDF) |
| 27 | Altered central pain processing in fibromyalgia—A multimodal neuroimaging case-control study using arterial spin labelling | 2.3 | 17 | Citations (PDF) |
| 28 | Biodegradable- Versus Durable-Polymer Drug-Eluting Stents for STEMI | 3.0 | 51 | Citations (PDF) |
| 29 | One-Year Outcomes of a Randomized Trial Comparing a Self-Expanding With a Balloon-Expandable Transcatheter Aortic Valve | 18.0 | 13 | Citations (PDF) |
| 30 | Coagulopathy of hospitalised COVID-19: A Pragmatic Randomised Controlled Trial of Therapeutic Anticoagulation versus Standard Care as a Rapid Response to the COVID-19 Pandemic (RAPID COVID COAG – RAPID Trial): A structured summary of a study protocol for a randomised controlled trial | 2.0 | 24 | Citations (PDF) |
| 31 | Effectiveness of Systematic Echocardiographic Screening for Rheumatic Heart Disease in Nepalese Schoolchildren | 11.1 | 36 | Citations (PDF) |
| 32 | Single early palliative care intervention added to usual oncology care for patients with advanced cancer: A randomized controlled trial (SENS Trial) | 3.0 | 30 | Citations (PDF) |
| 33 | The mobility gap: estimating mobility thresholds required to control SARS-CoV-2 in CanadaCmaj, 2021, 193, E592-E600 | 1.2 | 19 | Citations (PDF) |
| 34 | Adherence at 2 years with distribution of essential medicines at no charge: The CLEAN Meds randomized clinical trial | 8.0 | 19 | Citations (PDF) |
| 35 | Catching a resurgence: Increase in SARS-CoV-2 viral RNA identified in wastewater 48 h before COVID-19 clinical tests and 96 h before hospitalizations | 8.3 | 199 | Citations (PDF) |
| 36 | External validation of the
GRACE
risk score 2.0 in the contemporary
all‐comers GLOBAL LEADERS
trial | 1.7 | 1 | Citations (PDF) |
| 37 | The association of preoperative blood markers with postoperative readmissions following arthroplasty | 2.8 | 13 | Citations (PDF) |
| 38 | Guía ESC 2020 sobre el diagnóstico y tratamiento del síndrome coronario agudo sin elevación del segmento ST | 1.1 | 27 | Citations (PDF) |
| 39 | Mixed methods feasibility study for the surviving opioid overdose with naloxone education and resuscitation (SOONER) trial | 1.9 | 8 | Citations (PDF) |
| 40 | Écart de mobilité : estimation des seuils de mobilité requis pour maîtriser le SRAS-CoV-2 au CanadaCmaj, 2021, 193, E921-E930 | 1.2 | 0 | Citations (PDF) |
| 41 | Most published meta-regression analyses based on aggregate data suffer from methodological pitfalls: a meta-epidemiological study | 2.5 | 156 | Citations (PDF) |
| 42 | Debate: Prasugrel rather than ticagrelor is the preferred treatment for NSTE-ACS patients who proceed to PCI and pretreatment should not be performed in patients planned for an early invasive strategy | 2.2 | 32 | Citations (PDF) |
| 43 | Empagliflozin Reduces Myocardial Extracellular Volume in Patients With Type 2 Diabetes and Coronary Artery Disease | 6.1 | 80 | Citations (PDF) |
| 44 | ‘Ticagrelor alone vs. dual antiplatelet therapy from 1 month after drug-eluting coronary stenting among patients with STEMI’: a post hoc analysis of the randomized GLOBAL LEADERS trial | 1.0 | 6 | Citations (PDF) |
| 45 | Guidelines for Reporting Trial Protocols and Completed Trials Modified Due to the COVID-19 Pandemic and Other Extenuating Circumstances | 16.5 | 279 | Citations (PDF) |
| 46 | Effect of Continuous Electrocardiogram Monitoring on Detection of Undiagnosed Atrial Fibrillation After Hospitalization for Cardiac Surgery | 6.6 | 56 | Citations (PDF) |
| 47 | Effects of the PCSK9 antibody alirocumab on coronary atherosclerosis in patients with acute myocardial infarction: a serial, multivessel, intravascular ultrasound, near-infrared spectroscopy and optical coherence tomography imaging study–Rationale and design of the PACMAN-AMI trial | 2.9 | 38 | Citations (PDF) |
| 48 | 2021 ESC/EACTS Guidelines for the management of valvular heart disease | 1.4 | 540 | Citations (PDF) |
| 49 | Dual Antiplatelet Therapy after PCI in Patients at High Bleeding Risk | 34.5 | 510 | Citations (PDF) |
| 50 | Comparative frequency and prognostic impact of myocardial injury in hospitalized patients with COVID-19 and Influenza | 2.5 | 17 | Citations (PDF) |
| 51 | Abbreviated Antiplatelet Therapy in Patients at High Bleeding Risk With or Without Oral Anticoagulant Therapy After Coronary Stenting: An Open-Label, Randomized, Controlled Trial | 18.0 | 75 | Citations (PDF) |
| 52 | Acute kidney injury in patients with acute coronary syndrome undergoing invasive management treated with bivalirudin vs. unfractionated heparin: insights from the MATRIX trial | 1.0 | 5 | Citations (PDF) |
| 53 | Sodium‐Glucose Cotransporter 2 Inhibitors, All‐Cause Mortality, and Cardiovascular Outcomes in Adults with Type 2 Diabetes: A Bayesian Meta‐Analysis and Meta‐Regression | 4.0 | 23 | Citations (PDF) |
| 54 | Efficacy and Safety of Ticagrelor Monotherapy by Clinical Presentation: Pre‐Specified Analysis of the GLOBAL LEADERS Trial | 4.0 | 47 | Citations (PDF) |
| 55 | A disproportionate epidemic: COVID-19 cases and deaths among essential workers in Toronto, Canada | 1.7 | 41 | Citations (PDF) |
| 56 | Cold pain hypersensitivity predicts trajectories of pain and disability after low back surgery: a prospective cohort study | 4.2 | 22 | Citations (PDF) |
| 57 | Age and Sex Specific Prevalence of Clinical and Screen-Detected Atrial Fibrillation in Hospitalized Patients | 2.5 | 8 | Citations (PDF) |
| 58 | Drug‐Eluting or Bare‐Metal Stents for Left Anterior Descending or Left Main Coronary Artery Revascularization | 4.0 | 13 | Citations (PDF) |
| 59 | Evaluation of Biomarkers in Critical Care and Perioperative Medicine | 2.2 | 15 | Citations (PDF) |
| 60 | Risk-stratification of febrile African children at risk of sepsis using sTREM-1 as basis for a rapid triage test | 13.7 | 40 | Citations (PDF) |
| 61 | Heterogeneity of Treatment Effects in an Analysis of Pooled Individual Patient Data From Randomized Trials of Device Closure of Patent Foramen Ovale After Stroke | 16.5 | 218 | Citations (PDF) |
| 62 | Accuracy of Cardiovascular Trial Outcome Ascertainment and Treatment Effect Estimates from Routine Health Data: A Systematic Review and Meta-Analysis | 4.1 | 13 | Citations (PDF) |
| 63 | First-year Analysis of the Operating Room Black Box Study | 4.6 | 190 | Citations (PDF) |
| 64 | Effect on Treatment Adherence of Distributing Essential Medicines at No Charge | 10.6 | 57 | Citations (PDF) |
| 65 | Clinical relevance of ticagrelor monotherapy following 1‐month dual antiplatelet therapy after bifurcation percutaneous coronary intervention: Insight from GLOBAL LEADERS trial | 1.7 | 19 | Citations (PDF) |
| 66 | 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes | 2.2 | 6,243 | Citations (PDF) |
| 67 | 2019 ESC/EAS Guidelines for the management of dyslipidaemias:
lipid modification to reduce cardiovascular risk | 2.2 | 8,053 | Citations (PDF) |
| 68 | 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD | 2.2 | 3,616 | Citations (PDF) |
| 69 | 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS) | 2.2 | 4,235 | Citations (PDF) |
| 70 | Association of Sex With Outcomes in Patients Undergoing Percutaneous Coronary Intervention | 11.1 | 76 | Citations (PDF) |
| 71 | Association of Pulse Pressure With Clinical Outcomes in Patients Under Different Antiplatelet Strategies After Percutaneous Coronary Intervention: Analysis of GLOBAL LEADERS | 2.6 | 2 | Citations (PDF) |
| 72 | Effect of Empagliflozin on Erythropoietin Levels, Iron Stores, and Red Blood Cell Morphology in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease | 18.0 | 328 | Citations (PDF) |
| 73 | Paediatric reference values for total psoas muscle area | 9.1 | 107 | Citations (PDF) |
| 74 | Impact of established cardiovascular disease on outcomes in the randomized global leaders trial | 1.7 | 9 | Citations (PDF) |
| 75 | Whole milk compared with reduced-fat milk and childhood overweight: a systematic review and meta-analysis | 4.7 | 71 | Citations (PDF) |
| 76 | Association between post-percutaneous coronary intervention bivalirudin infusion and net adverse clinical events: a post hoc analysis of the GLOBAL LEADERS study | 4.0 | 11 | Citations (PDF) |
| 77 | Randomized, Controlled Trial Comparing Mitral Valve Repair With Leaflet Resection Versus Leaflet Preservation on Functional Mitral Stenosis | 18.0 | 37 | Citations (PDF) |
| 78 | Improving the Design of Future PCI Trials for Stable Coronary Artery Disease | 2.3 | 9 | Citations (PDF) |
| 79 | Blood glucose, diabetes and metabolic control in patients with community-acquired pneumonia | 7.5 | 10 | Citations (PDF) |
| 80 | Bias and Loss to Follow‐Up in Cardiovascular Randomized Trials: A Systematic Review | 4.0 | 15 | Citations (PDF) |
| 81 | Randomized trials of invasive cardiovascular interventions that include a placebo control: a systematic review and meta-analysis | 2.2 | 21 | Citations (PDF) |
| 82 | Protecting Frontline Health Care Workers from COVID-19 with Hydroxychloroquine Pre-exposure Prophylaxis: A structured summary of a study protocol for a randomised placebo-controlled multisite trial in Toronto, Canada | 2.0 | 7 | Citations (PDF) |
| 83 | Effets du climat et des interventions de santé publique sur la pandémie de COVID-19 : une étude de cohorte prospectiveCmaj, 2020, 192, E1374-E1382 | 1.2 | 1 | Citations (PDF) |
| 84 | Time-varying intensity of mechanical ventilation and mortality in patients with acute respiratory failure: a registry-based, prospective cohort study | 23.3 | 193 | Citations (PDF) |
| 85 | Comparative Methodological Assessment of the Randomized GLOBAL LEADERS Trial Using Total Ischemic and Bleeding Events | 4.1 | 17 | Citations (PDF) |
| 86 | Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19 | 16.5 | 2,116 | Citations (PDF) |
| 87 | Evaluation of Cumulative Meta-analysis of Rare Events as a Tool for Clinical Trials Safety Monitoring | 6.6 | 3 | Citations (PDF) |
| 88 | Anticoagulant interventions in hospitalized patients with COVID‐19: A scoping review of randomized controlled trials and call for international collaboration | 3.8 | 102 | Citations (PDF) |
| 89 | Impact of Bleeding and Myocardial Infarction on Mortality in All-Comer Patients Undergoing Percutaneous Coronary Intervention | 4.8 | 27 | Citations (PDF) |
| 90 | Corticosteroid therapy for critically ill patients with COVID-19: A structured summary of a study protocol for a prospective meta-analysis of randomized trials | 2.0 | 37 | Citations (PDF) |
| 91 | The effects of intravenous iron supplementation on fatigue and general health in non-anemic blood donors with iron deficiency: a randomized placebo-controlled superiority trial | 3.4 | 20 | Citations (PDF) |
| 92 | Risk of Paradoxical Embolism (RoPE)–Estimated Attributable Fraction Correlates With the Benefit of Patent Foramen Ovale Closure | 5.9 | 94 | Citations (PDF) |
| 93 | Global Fractional Flow Reserve Value Predicts 5‐Year Outcomes in Patients With Coronary Atherosclerosis But Without Ischemia | 4.0 | 14 | Citations (PDF) |
| 94 | Impact of climate and public health interventions on the COVID-19 pandemic: a prospective cohort studyCmaj, 2020, 192, E566-E573 | 1.2 | 211 | Citations (PDF) |
| 95 | Effect of Biomechanical Footwear on Knee Pain in People With Knee Osteoarthritis | 16.5 | 48 | Citations (PDF) |
| 96 | Cow’s Milk Fat Obesity pRevention Trial (CoMFORT): a primary care embedded randomised controlled trial protocol to determine the effect of cow’s milk fat on child adiposity | 1.9 | 4 | Citations (PDF) |
| 97 | Glucose-lowering drugs or strategies, atherosclerotic cardiovascular events, and heart failure in people with or at risk of type 2 diabetes: an updated systematic review and meta-analysis of randomised cardiovascular outcome trials | 21.7 | 142 | Citations (PDF) |
| 98 | Natural History of Asymptomatic Severe Aortic Stenosis and the Association of Early Intervention With Outcomes | 11.1 | 61 | Citations (PDF) |
| 99 | Does empagliflozin modulate the autonomic nervous system among individuals with type 2 diabetes and coronary artery disease? The EMPA-HEART CardioLink-6 Holter analysis | 2.4 | 25 | Citations (PDF) |
| 100 | DAPT Score and the Impact of Ticagrelor Monotherapy During the Second Year After PCI | 3.0 | 19 | Citations (PDF) |
| 101 | Association of diabetes with outcomes in patients undergoing contemporary percutaneous coronary intervention: Pre-specified subgroup analysis from the randomized GLOBAL LEADERS study | 1.5 | 57 | Citations (PDF) |
| 102 | The impact of pre-procedure heart rate on adverse clinical outcomes in patients undergoing percutaneous coronary intervention: Results from a 2-year follow-up of the GLOBAL LEADERS trial | 1.5 | 2 | Citations (PDF) |
| 103 | A statistical primer on subgroup analyses | 1.4 | 14 | Citations (PDF) |
| 104 | Randomized Trials in Cardiac Surgery | 2.3 | 39 | Citations (PDF) |
| 105 | Usefulness of the updated logistic clinical SYNTAX score after percutaneous coronary intervention in patients with prior coronary artery bypass graft surgery: Insights from the GLOBAL LEADERS trial | 1.7 | 6 | Citations (PDF) |
| 106 | The association of body mass index with long-term clinical outcomes after ticagrelor monotherapy following abbreviated dual antiplatelet therapy in patients undergoing percutaneous coronary intervention: a prespecified sub-analysis of the GLOBAL LEADERS Trial | 2.8 | 20 | Citations (PDF) |
| 107 | Renal Hyperfiltration and the Effect of Intensive vs. Standard Blood Pressure Lowering on Cardiovascular Outcomes | 0.4 | 0 | Citations (PDF) |
| 108 | 2018 ESC/EACTS Guidelines on myocardial revascularization | 2.2 | 6,099 | Citations (PDF) |
| 109 | Considerations for the choice between coronary artery bypass grafting and percutaneous coronary intervention as revascularization strategies in major categories of patients with stable multivessel coronary artery disease: an accompanying article of the task force of the 2018 ESC/EACTS guidelines on myocardial revascularization | 2.2 | 77 | Citations (PDF) |
| 110 | Restrictive compared with liberal red cell transfusion strategies in cardiac surgery: a meta-analysis | 2.2 | 110 | Citations (PDF) |
| 111 | 2018 ESC/EACTS Guidelines on myocardial revascularization | 1.4 | 504 | Citations (PDF) |
| 112 | Standardized classification and framework for reporting, interpreting, and analysing medication non-adherence in cardiovascular clinical trials: a consensus report from the Non-adherence Academic Research Consortium (NARC) | 2.2 | 82 | Citations (PDF) |
| 113 | Long-Term Effect of Ultrathin-Strut Versus Thin-Strut Drug-Eluting Stents in Patients With Small Vessel Coronary Artery Disease Undergoing Percutaneous Coronary Intervention | 4.8 | 29 | Citations (PDF) |
| 114 | Impact of long-term ticagrelor monotherapy following 1-month dual antiplatelet therapy in patients who underwent complex percutaneous coronary intervention: insights from the Global Leaders trial | 2.2 | 119 | Citations (PDF) |
| 115 | Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy | 34.5 | 568 | Citations (PDF) |
| 116 | Safety and efficacy of a self-expanding versus a balloon-expandable bioprosthesis for transcatheter aortic valve replacement in patients with symptomatic severe aortic stenosis: a randomised non-inferiority trial | 62.1 | 265 | Citations (PDF) |
| 117 | Five‐Year Outcomes in Patients With Diabetes Mellitus Treated With Biodegradable Polymer Sirolimus‐Eluting Stents Versus Durable Polymer Everolimus‐Eluting Stents | 4.0 | 23 | Citations (PDF) |
| 118 | Ticagrelor Alone Versus Dual Antiplatelet Therapy From 1 Month After Drug-Eluting Coronary Stenting | 2.3 | 144 | Citations (PDF) |
| 119 | Ascertainment of Silent Myocardial Infarction in Patients Undergoing Percutaneous Coronary Intervention (from the GLOBAL LEADERS Trial) | 1.8 | 5 | Citations (PDF) |
| 120 | Effect of Empagliflozin on Left Ventricular Mass in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease | 18.0 | 509 | Citations (PDF) |
| 121 | 2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk | 1.5 | 2,220 | Citations (PDF) |
| 122 | Biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents in patients with ST-segment elevation myocardial infarction (BIOSTEMI): a single-blind, prospective, randomised superiority trial | 62.1 | 182 | Citations (PDF) |
| 123 | Percutaneous coronary intervention versus coronary artery bypass grafting in patients with three-vessel or left main coronary artery disease: 10-year follow-up of the multicentre randomised controlled SYNTAX trial | 62.1 | 586 | Citations (PDF) |
| 124 | Association of acute kidney injury and bleeding events with mortality after radial or femoral access in patients with acute coronary syndrome undergoing invasive management: secondary analysis of a randomized clinical trial | 2.2 | 27 | Citations (PDF) |
| 125 | Health system factors and caesarean sections in Kosovo: a cross-sectional study | 1.9 | 14 | Citations (PDF) |
| 126 | Adverse Events in the Operating Room: Definitions, Prevalence, and Characteristics. A Systematic Review | 2.3 | 44 | Citations (PDF) |
| 127 | A Positive Association Between Dietary Intake of Higher Cow's Milk-Fat Percentage and Non−High-Density Lipoprotein Cholesterol in Young Children | 2.0 | 9 | Citations (PDF) |
| 128 | Transcatheter aortic valve implantation vs. surgical aortic valve replacement for treatment of symptomatic severe aortic stenosis: an updated meta-analysis | 2.2 | 430 | Citations (PDF) |
| 129 | Drug-eluting or bare-metal stents for percutaneous coronary intervention: a systematic review and individual patient data meta-analysis of randomised clinical trials | 62.1 | 221 | Citations (PDF) |
| 130 | Caesarean section in uninsured women in the USA: systematic review and meta-analysis | 1.9 | 19 | Citations (PDF) |
| 131 | Clinical impact of a structured secondary cardiovascular prevention program following acute coronary syndromes: A prospective multicenter healthcare intervention | 2.3 | 7 | Citations (PDF) |
| 132 | Rationale and design of a prospective substudy of clinical endpoint adjudication processes within an investigator-reported randomised controlled trial in patients with coronary artery disease: the GLOBAL LEADERS Adjudication Sub-StudY (GLASSY) | 1.9 | 22 | Citations (PDF) |
| 133 | Predictive ability of ACEF and ACEF II score in patients undergoing percutaneous coronary intervention in the GLOBAL LEADERS study | 2.2 | 30 | Citations (PDF) |
| 134 | Can quantitative sensory tests predict failed back surgery? | 4.5 | 17 | Citations (PDF) |
| 135 | Increased subchondral bone thickness in hips with cam-type femoroacetabular impingement | 1.3 | 4 | Citations (PDF) |
| 136 | Predicting transition from acute to chronic low back pain with quantitative sensory tests—A prospective cohort study in the primary care setting | 3.0 | 27 | Citations (PDF) |
| 137 | Fractional flow reserve-guided percutaneous coronary intervention vs. medical therapy for patients with stable coronary lesions: meta-analysis of individual patient data | 2.2 | 196 | Citations (PDF) |
| 138 | Design and rationale of the Management of High Bleeding Risk Patients Post Bioresorbable Polymer Coated Stent Implantation With an Abbreviated Versus Standard DAPT Regimen (MASTER DAPT) Study | 2.9 | 61 | Citations (PDF) |
| 139 | Gender and age differences in outcomes of patients with acute coronary syndromes referred for coronary angiography | 1.7 | 5 | Citations (PDF) |
| 140 | Prospective cohort study of vitamin D and autism spectrum disorder diagnoses in early childhood | 5.2 | 9 | Citations (PDF) |
| 141 | Rationale and design of OPtimising thERapy to prevent Avoidable hospital
admissions in Multimorbid older people (OPERAM): a cluster randomised
controlled trial | 1.9 | 46 | Citations (PDF) |
| 142 | Non-Technical Skills for Surgeons (NOTSS): Critical appraisal of its measurement properties | 1.7 | 47 | Citations (PDF) |
| 143 | Prognostic Value of Early Postoperative Troponin T in Patients Undergoing Coronary Artery Bypass Grafting | 4.0 | 34 | Citations (PDF) |
| 144 | Actualización ESC 2017 sobre el tratamiento antiagregante plaquetario doble en la enfermedad coronaria, desarrollada en colaboración con la EACTS | 1.1 | 2 | Citations (PDF) |
| 145 | Case-based implementation of the 2017 ESC Focused Update on Dual Antiplatelet Therapy in Coronary Artery Disease | 2.2 | 29 | Citations (PDF) |
| 146 | Improved risk stratification of patients with acute coronary syndromes using a combination of hsTnT, NT-proBNP and hsCRP with the GRACE score | 1.0 | 76 | Citations (PDF) |
| 147 | Thrombus aspiration in acute coronary syndromes: prevalence, procedural success, change in serial troponin T levels and clinical outcomes in a contemporary Swiss cohort | 1.0 | 8 | Citations (PDF) |
| 148 | 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS) | 2.2 | 3,079 | Citations (PDF) |
| 149 | 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation | 2.2 | 8,761 | Citations (PDF) |
| 150 | 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS | 2.2 | 2,684 | Citations (PDF) |
| 151 | Report of an ESC-EAPCI Task Force on the evaluation and use of bioresorbable scaffolds for percutaneous coronary intervention: executive summary | 2.2 | 50 | Citations (PDF) |
| 152 | 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS | 1.4 | 316 | Citations (PDF) |
| 153 | Clinical Outcomes and Cost-Effectiveness of Fractional Flow Reserve–Guided Percutaneous Coronary Intervention in Patients With Stable Coronary Artery Disease | 18.0 | 243 | Citations (PDF) |
| 154 | Systematic review and meta-analysis of chordal replacement versus leaflet resection for posterior mitral leaflet prolapse | 2.6 | 65 | Citations (PDF) |
| 155 | Angiography Versus Hemodynamics to Predict the Natural History of Coronary Stenoses | 18.0 | 79 | Citations (PDF) |
| 156 | Homograft versus Conventional Prosthesis for Surgical Management of Aortic Valve Infective Endocarditis | 0.9 | 21 | Citations (PDF) |
| 157 | Fractional Flow Reserve and Quality-of-Life Improvement After Percutaneous Coronary Intervention in Patients With Stable Coronary Artery Disease | 18.0 | 43 | Citations (PDF) |
| 158 | Extracorporeal Membrane Oxygenation for Severe Acute Respiratory Distress Syndrome and Posterior Probability of Mortality Benefit in a Post Hoc Bayesian Analysis of a Randomized Clinical Trial | 16.5 | 472 | Citations (PDF) |
| 159 | Rate, Timing, Correlates, and Outcomes of Hemodynamic Valve Deterioration After Bioprosthetic Surgical Aortic Valve Replacement | 18.0 | 115 | Citations (PDF) |
| 160 | The performance of non-invasive tests to rule-in and rule-out significant coronary artery stenosis in patients with stable angina: a meta-analysis focused on post-test disease probability | 2.2 | 502 | Citations (PDF) |
| 161 | Should thoracic paravertebral blocks be used to prevent chronic postsurgical pain after breast cancer surgery? A systematic analysis of evidence in light of IMMPACT recommendationsPain, 2018, 159, 1955-1971 | 4.2 | 47 | Citations (PDF) |
| 162 | Five-Year Outcomes with PCI Guided by Fractional Flow Reserve | 34.5 | 820 | Citations (PDF) |
| 163 | Effect of single-dose imipramine on chronic low-back and experimental pain. A randomized controlled trial | 2.3 | 21 | Citations (PDF) |
| 164 | 2018 ESC/ESH Guidelines for the management of arterial hypertension | 2.2 | 8,913 | Citations (PDF) |
| 165 | Radial versus femoral access and bivalirudin versus unfractionated heparin in invasively managed patients with acute coronary syndrome (MATRIX): final 1-year results of a multicentre, randomised controlled trial | 62.1 | 280 | Citations (PDF) |
| 166 | 2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy | 2.2 | 2,063 | Citations (PDF) |
| 167 | Six-Month Outcomes after Restrictive or Liberal Transfusion for Cardiac Surgery | 34.5 | 231 | Citations (PDF) |
| 168 | Ultrathin-strut, biodegradable-polymer, sirolimus-eluting stents versus thin-strut, durable-polymer, everolimus-eluting stents for percutaneous coronary revascularisation: 5-year outcomes of the BIOSCIENCE randomised trial | 62.1 | 125 | Citations (PDF) |
| 169 | Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial | 62.1 | 736 | Citations (PDF) |
| 170 | Predictive value of the age, creatinine, and ejection fraction (ACEF) score in patients with acute coronary syndromes | 2.2 | 49 | Citations (PDF) |
| 171 | Midterm clinical outcomes with everolimus-eluting bioresorbable scaffolds versus everolimus-eluting metallic stents for percutaneous coronary interventions: a meta-analysis of randomised trials | 3.0 | 43 | Citations (PDF) |
| 172 | Evaluating the importance of sham-controlled trials in the investigation of medical devices in interventional cardiology | 3.0 | 15 | Citations (PDF) |
| 173 | Report of an ESC-EAPCI Task Force on the evaluation and use of bioresorbable scaffolds for percutaneous coronary intervention: executive summary | 3.0 | 38 | Citations (PDF) |
| 174 | Caesarean sections and for-profit status of hospitals: systematic review and meta-analysis | 1.9 | 81 | Citations (PDF) |
| 175 | Protocol for a scoping review of post-trial extensions of randomised controlled trials using individually linked administrative and registry data | 1.9 | 6 | Citations (PDF) |
| 176 | Effect of standardized training on the reliability of the Cochrane risk of bias assessment tool: a prospective study | 4.7 | 54 | Citations (PDF) |
| 177 | Impact of total arterial revascularization on long term survival: A systematic review and meta-analysis of 130,305 patients | 2.2 | 79 | Citations (PDF) |
| 178 | Rates and predictors of hospital readmission after transcatheter aortic valve implantation | 2.2 | 64 | Citations (PDF) |
| 179 | Adverse events while awaiting myocardial revascularization: a systematic review and meta-analysis | 1.4 | 46 | Citations (PDF) |
| 180 | A systematic review and meta-analysis of in situ versus composite bilateral internal thoracic artery grafting | 2.6 | 52 | Citations (PDF) |
| 181 | Protocol for a randomised controlled trial evaluating the effects of providing essential medicines at no charge: the Carefully seLected and Easily Accessible at No Charge Medicines (CLEAN Meds) trial | 1.9 | 7 | Citations (PDF) |
| 182 | Acute Kidney Injury After Radial or Femoral Access for Invasive Acute Coronary Syndrome Management | 2.3 | 151 | Citations (PDF) |
| 183 | Axillary versus innominate artery cannulation for antegrade cerebral perfusion in aortic surgery: design of the Aortic Surgery Cerebral Protection Evaluation (ACE) CardioLink-3 randomised trial | 1.9 | 21 | Citations (PDF) |
| 184 | Latest evidence on transcatheter aortic valve implantation vs. surgical aortic valve replacement for the treatment of aortic stenosis in high and intermediate-risk patients | 1.6 | 14 | Citations (PDF) |
| 185 | Effects of coronary artery disease in patients undergoing transcatheter aortic valve implantation: A study of age- and gender-matched cohorts | 2.2 | 30 | Citations (PDF) |
| 186 | Radial versus femoral access in patients with acute coronary syndromes with or without ST-segment elevation | 2.2 | 62 | Citations (PDF) |
| 187 | Radiation Exposure and Vascular Access in Acute Coronary Syndromes | 2.3 | 78 | Citations (PDF) |
| 188 | Impact of Patient and Lesion Complexity on Long-Term Outcomes Following Coronary Revascularization With New-Generation Drug-Eluting Stents | 1.8 | 11 | Citations (PDF) |
| 189 | Response by Piroth et al to Letter Regarding Article, “Prognostic Value of Fractional Flow Reserve Measured Immediately After Drug-Eluting Stent Implantation” | 4.8 | 13 | Citations (PDF) |
| 190 | 2017 ESC/EACTS Guidelines for the management of valvular heart disease | 2.2 | 5,609 | Citations (PDF) |
| 191 | Caesarean sections and private insurance: systematic review and meta-analysis | 1.9 | 56 | Citations (PDF) |
| 192 | Quantitative sensory tests fairly reflect immediate effects of oxycodone in chronic low-back pain | 1.5 | 6 | Citations (PDF) |
| 193 | Measurement Error of a Simplified Protocol for Quantitative Sensory Tests in Chronic Pain Patients | 2.6 | 4 | Citations (PDF) |
| 194 | Prognostic Value of Fractional Flow Reserve Measured Immediately After Drug-Eluting Stent Implantation | 4.8 | 139 | Citations (PDF) |
| 195 | Restrictive or Liberal Red-Cell Transfusion for Cardiac Surgery | 34.5 | 712 | Citations (PDF) |
| 196 | Effectiveness of non-steroidal anti-inflammatory drugs for the treatment of pain in knee and hip osteoarthritis: a network meta-analysis | 62.1 | 454 | Citations (PDF) |
| 197 | Cysteine-rich angiogenic inducer 61 (Cyr61): a novel soluble biomarker of acute myocardial injury improves risk stratification after acute coronary syndromes | 2.2 | 52 | Citations (PDF) |
| 198 | A randomized multicenter trial comparing the XIENCE everolimus eluting stent with the CYPHER sirolimus eluting stent in the treatment of female patients with de novo coronary artery lesions: The SPIRIT WOMEN study | 2.3 | 6 | Citations (PDF) |
| 199 | Does access to clinical study reports from the European Medicines Agency reduce reporting biases? A systematic review and meta-analysis of randomized controlled trials on the effect of erythropoiesis-stimulating agents in cancer patients | 2.3 | 9 | Citations (PDF) |
| 200 | Randomised trial of mitral valve repair with leaflet resection versus leaflet preservation on functional mitral stenosis (The CAMRA CardioLink-2 Trial) | 1.9 | 13 | Citations (PDF) |
| 201 | Comparison of procedural and clinical outcomes with Evolut R versus Medtronic CoreValve: a Swiss TAVI registry analysis | 3.0 | 51 | Citations (PDF) |
| 202 | Conditioned Pain Modulation in Patients With Acute and Chronic Low Back Pain | 2.3 | 72 | Citations (PDF) |
| 203 | Preprocedural High-Sensitivity Cardiac Troponin T and Clinical Outcomes in Patients With Stable Coronary Artery Disease Undergoing Elective Percutaneous Coronary Intervention | 4.8 | 21 | Citations (PDF) |
| 204 | Radial Versus Femoral Access for Coronary Interventions Across the Entire Spectrum of Patients With Coronary Artery Disease | 3.0 | 496 | Citations (PDF) |
| 205 | First generation versus second generation drug‐eluting stents for the treatment of bifurcations: 5‐year follow‐up of the LEADERS all‐comers randomized trial | 1.7 | 53 | Citations (PDF) |
| 206 | Transcatheter aortic valve implantation vs. surgical aortic valve replacement for treatment of severe aortic stenosis: a meta-analysis of randomized trials | 2.2 | 320 | Citations (PDF) |
| 207 | Intra-articular Corticosteroids for Osteoarthritis of the Knee | 16.5 | 60 | Citations (PDF) |
| 208 | Surgical versus conservative treatment for lumbar disc herniation: a prospective cohort study | 1.9 | 180 | Citations (PDF) |
| 209 | Comparative Efficacy of Seven Psychotherapeutic Interventions for Patients with Depression: A Network Meta-Analysis | 1.1 | 110 | Citations (PDF) |
| 210 | Plasma ceramides predict cardiovascular death in patients with stable coronary artery disease and acute coronary syndromes beyond LDL-cholesterol | 2.2 | 628 | Citations (PDF) |
| 211 | Ultrathin Strut Biodegradable Polymer Sirolimus‐Eluting Stent Versus Durable‐Polymer Everolimus‐Eluting Stent for Percutaneous Coronary Revascularization: 2‐Year Results of the BIOSCIENCE Trial | 4.0 | 57 | Citations (PDF) |
| 212 | Ten-year clinical outcomes of first-generation drug-eluting stents: the Sirolimus-Eluting vs. Paclitaxel-Eluting Stents for Coronary Revascularization (SIRTAX) VERY LATE trial | 2.2 | 93 | Citations (PDF) |
| 213 | A Prospective Natural History Study of Coronary Atherosclerosis Using Fractional Flow Reserve | 2.3 | 144 | Citations (PDF) |
| 214 | Duration of Triple Antithrombotic Therapy and Outcomes Among Patients Undergoing Percutaneous Coronary Intervention | 3.0 | 26 | Citations (PDF) |
| 215 | Prevalence of Subclinical Rheumatic Heart Disease in Eastern Nepal | 11.1 | 65 | Citations (PDF) |
| 216 | Discriminative ability of reflex receptive fields to distinguish patients with acute and chronic low back painPain, 2016, 157, 2664-2671 | 4.2 | 7 | Citations (PDF) |
| 217 | External validity of the “all-comers” design: insights from the BIOSCIENCE trial | 2.8 | 11 | Citations (PDF) |
| 218 | Percutaneous Coronary Interventions for the Treatment of Stenoses in Small Coronary Arteries | 3.0 | 74 | Citations (PDF) |
| 219 | Effect of Diabetes Mellitus on Frequency of Adverse Events in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention | 1.8 | 19 | Citations (PDF) |
| 220 | Mechanisms of Very Late Drug-Eluting Stent Thrombosis Assessed by Optical Coherence Tomography | 18.0 | 319 | Citations (PDF) |
| 221 | Prognostic value of PCSK9 levels in patients with acute coronary syndromes | 2.2 | 137 | Citations (PDF) |
| 222 | Device Closure of Patent Foramen Ovale After Stroke | 2.3 | 205 | Citations (PDF) |
| 223 | Impact of Diabetic Status on Outcomes After Revascularization With Drug-Eluting Stents in Relation to Coronary Artery Disease Complexity | 4.8 | 110 | Citations (PDF) |
| 224 | Risk and timing of recurrent ischemic events among patients with stable ischemic heart disease, non–ST-segment elevation acute coronary syndrome, and ST-segment elevation myocardial infarction | 2.9 | 79 | Citations (PDF) |
| 225 | Post‐Procedural Troponin Elevation and Clinical Outcomes Following Transcatheter Aortic Valve Implantation | 4.0 | 52 | Citations (PDF) |
| 226 | Revascularization Treatment of Emergency Patients with Acute ST-Segment Elevation Myocardial Infarction in Switzerland: Results from a Nationwide, Cross-Sectional Study in Switzerland for 2010-2011 | 2.3 | 6 | Citations (PDF) |
| 227 | Angiographic complexity of coronary artery disease according to SYNTAX score and clinical outcomes after revascularisation with newer-generation drug-eluting stents: a substudy of the BIOSCIENCE trial | 3.0 | 13 | Citations (PDF) |
| 228 | External validity of a contemporaneous primary percutaneous coronary intervention trial in patients with acute ST-elevation myocardial infarction: insights from a single-centre investigation | 3.0 | 4 | Citations (PDF) |
| 229 | Biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents for primary percutaneous coronary revascularisation of acute myocardial infarction | 3.0 | 32 | Citations (PDF) |
| 230 | Screening for Rheumatic Heart Disease among Peruvian Children: A Two-Stage Sampling Observational Study | 2.3 | 17 | Citations (PDF) |
| 231 | Age- and Gender-related Disparities in Primary Percutaneous Coronary Interventions for Acute ST-segment elevation Myocardial Infarction | 2.3 | 32 | Citations (PDF) |
| 232 | The association between in-stent neoatherosclerosis and native coronary artery disease progression: a long-term angiographic and optical coherence tomography cohort study | 2.2 | 91 | Citations (PDF) |
| 233 | Clinical Impact of Gastrointestinal Bleeding in Patients Undergoing Percutaneous Coronary Interventions | 4.8 | 89 | Citations (PDF) |
| 234 | Low statin use in adults hospitalized with acute coronary syndrome | 2.8 | 20 | Citations (PDF) |
| 235 | Subclinical Thyroid Dysfunction and Fracture Risk | 16.5 | 323 | Citations (PDF) |
| 236 | Procedural Results and Clinical Outcomes of Transcatheter Aortic Valve Implantation in Switzerland | 4.8 | 66 | Citations (PDF) |
| 237 | Biolimus-eluting stent with biodegradable polymer improves clinical outcomes in patients with acute myocardial infarctionHeart, 2015, 101, 271-278 | 3.9 | 17 | Citations (PDF) |
| 238 | Fractional Flow Reserve–Guided PCI | 34.5 | 1 | Citations (PDF) |
| 239 | Safety of Prasugrel Loading Doses in Patients Pre-Loaded With Clopidogrel in the Setting of Primary Percutaneous Coronary Intervention | 3.0 | 6 | Citations (PDF) |
| 240 | Clinical Outcomes According to Diabetic Status in Patients Treated With Biodegradable Polymer Sirolimus-Eluting Stents Versus Durable Polymer Everolimus-Eluting Stents | 4.8 | 34 | Citations (PDF) |
| 241 | Prevalence and management of familial hypercholesterolaemia in patients with acute coronary syndromes | 2.2 | 142 | Citations (PDF) |
| 242 | Report of a European Society of Cardiology-European Association of Percutaneous Cardiovascular Interventions task force on the evaluation of coronary stents in Europe: executive summary | 2.2 | 213 | Citations (PDF) |
| 243 | BEST—When a Study Falls Short of Its Acronym | 1.8 | 1 | Citations (PDF) |
| 244 | Aspiration Thrombectomy for Treatment of ST-segment Elevation Myocardial Infarction: a Meta-analysis of 26 Randomized Trials in 11 943 Patients | 0.4 | 8 | Citations (PDF) |
| 245 | Safety and Efficacy of Resolute Zotarolimus-Eluting Stents Compared With Everolimus-Eluting Stents | 4.8 | 73 | Citations (PDF) |
| 246 | Comparison of a Novel Biodegradable Polymer Sirolimus-Eluting Stent With a Durable Polymer Everolimus-Eluting Stent | 4.8 | 198 | Citations (PDF) |
| 247 | Metamizole-Associated Adverse Events: A Systematic Review and Meta-Analysis | 2.3 | 148 | Citations (PDF) |
| 248 | Radial versus femoral access in patients with acute coronary syndromes undergoing invasive management: a randomised multicentre trial | 62.1 | 1,224 | Citations (PDF) |
| 249 | Consensus on the Need for a Hierarchical List of Patient-reported Pain Outcomes for Metaanalyses of Knee Osteoarthritis Trials: An OMERACT Objective | 2.3 | 18 | Citations (PDF) |
| 250 | Safety profile of prasugrel and clopidogrel in patients with acute coronary syndromes in SwitzerlandHeart, 2015, 101, 854-863 | 3.9 | 41 | Citations (PDF) |
| 251 | Validation of the Valve Academic Research Consortium Bleeding Definition in Patients With Severe Aortic Stenosis Undergoing Transcatheter Aortic Valve Implantation | 4.0 | 30 | Citations (PDF) |
| 252 | Intra-articular corticosteroid for knee osteoarthritis | 2.1 | 294 | Citations (PDF) |
| 253 | Effect of B-type Natriuretic Peptides on Long-Term Outcomes After Transcatheter Aortic Valve Implantation | 1.8 | 54 | Citations (PDF) |
| 254 | Bivalirudin or Unfractionated Heparin in Acute Coronary Syndromes | 34.5 | 376 | Citations (PDF) |
| 255 | Percutaneous coronary interventional strategies for treatment of in-stent restenosis: a network meta-analysis | 62.1 | 327 | Citations (PDF) |
| 256 | Current State of Reporting Pain Outcomes in Cochrane Reviews of Chronic Musculoskeletal Pain Conditions and Considerations for an OMERACT Research Agenda | 2.3 | 10 | Citations (PDF) |
| 257 | Trombectomía por aspiración para el tratamiento del infarto agudo de miocardio con elevación del segmento ST: un metanálisis de 26 ensayos aleatorizados con 11.943 pacientes | 1.1 | 13 | Citations (PDF) |
| 258 | Comparative Effectiveness and Safety of New-Generation Versus Early-Generation Drug-Eluting Stents According to Complexity of Coronary Artery Disease | 3.0 | 39 | Citations (PDF) |
| 259 | Association of radiographic osteoarthritis, pain on passive movement and knee range of motion: A cross-sectional study | 2.3 | 18 | Citations (PDF) |
| 260 | Effect of high-intensity statin therapy on atherosclerosis in non-infarct-related coronary arteries (IBIS-4): a serial intravascular ultrasonography study | 2.2 | 204 | Citations (PDF) |
| 261 | Percutaneous closure of patent foramen ovale in patients with cryptogenic embolism: a network meta-analysis | 2.2 | 116 | Citations (PDF) |
| 262 | Long-term outcome of elderly patients with severe aortic stenosis as a function of treatment modality | 3.9 | 32 | Citations (PDF) |
| 263 | Clinical outcome of patients with stable ischaemic heart disease as compared to those with acute coronary syndromes after percutaneous coronary intervention | 3.0 | 10 | Citations (PDF) |
| 264 | Quality of Care after Acute Coronary Syndromes in a Prospective Cohort with Reasons for Non-Prescription of Recommended Medications | 2.3 | 31 | Citations (PDF) |
| 265 | Organ Donation in Switzerland - An Analysis of Factors Associated with Consent Rate | 2.3 | 20 | Citations (PDF) |
| 266 | Sono-Electro-Magnetic Therapy for Treating Chronic Pelvic Pain Syndrome in Men: A Randomized, Placebo-Controlled, Double-Blind Trial | 2.3 | 29 | Citations (PDF) |
| 267 | Factors affecting screening for hepatocellular carcinoma | 1.5 | 19 | Citations (PDF) |
| 268 | Active surveillance for rheumatic heart disease in endemic regions: a systematic review and meta-analysis of prevalence among children and adolescents | 13.3 | 189 | Citations (PDF) |
| 269 | Effects of erythropoiesis-stimulating agents on fatigue- and anaemia-related symptoms in cancer patients: systematic review and meta-analyses of published and unpublished data | 5.5 | 61 | Citations (PDF) |
| 270 | Response to Letter Regarding Article, “Cost-Effectiveness of Percutaneous Coronary Intervention in Patients With Stable Coronary Artery Disease and Abnormal Fractional Flow Reserve” | 18.0 | 0 | Citations (PDF) |
| 271 | Coronary artery disease severity and aortic stenosis: clinical outcomes according to SYNTAX score in patients undergoing transcatheter aortic valve implantation | 2.2 | 173 | Citations (PDF) |
| 272 | Systematic reviews and meta-analyses of randomized trials: principles and pitfalls | 2.2 | 223 | Citations (PDF) |
| 273 | 2014 ESC/EACTS Guidelines on myocardial revascularization | 1.4 | 2,217 | Citations (PDF) |
| 274 | Coronary evaginations are associated with positive vessel remodelling and are nearly absent following implantation of newer-generation drug-eluting stents: an optical coherence tomography and intravascular ultrasound study | 2.2 | 72 | Citations (PDF) |
| 275 | Validation and reclassification of MGAP and GAP in hospital settings using data from the Trauma Audit and Research Network | 2.4 | 16 | Citations (PDF) |
| 276 | The association between admission systolic blood pressure and mortality in significant traumatic brain injury: A multi-centre cohort study | 1.7 | 98 | Citations (PDF) |
| 277 | Differential healing response attributed to culprit lesions of patients with acute coronary syndromes and stable coronary artery after implantation of drug-eluting stents: An optical coherence tomography study | 2.2 | 46 | Citations (PDF) |
| 278 | Comparison of Newer-Generation Drug-Eluting With Bare-Metal Stents in Patients With Acute ST-Segment Elevation Myocardial Infarction | 3.0 | 100 | Citations (PDF) |
| 279 | Ultrathin strut biodegradable polymer sirolimus-eluting stent versus durable polymer everolimus-eluting stent for percutaneous coronary revascularisation (BIOSCIENCE): a randomised, single-blind, non-inferiority trial | 62.1 | 256 | Citations (PDF) |
| 280 | Predictors of Permanent Pacemaker Implantation in Patients With Severe Aortic Stenosis Undergoing TAVR | 2.3 | 621 | Citations (PDF) |
| 281 | 2014 ESC/EACTS Guidelines on myocardial revascularization | 2.2 | 4,373 | Citations (PDF) |
| 282 | Fractional Flow Reserve–Guided PCI for Stable Coronary Artery Disease | 34.5 | 1,015 | Citations (PDF) |
| 283 | Biolimus-Eluting Stents With Biodegradable Polymer Versus Bare-Metal Stents in Acute Myocardial Infarction | 4.8 | 59 | Citations (PDF) |
| 284 | Comparative effectiveness of long term drug treatment strategies to prevent asthma exacerbations: network meta-analysis | 0.2 | 57 | Citations (PDF) |
| 285 | Revascularisation versus medical treatment in patients with stable coronary artery disease: network meta-analysis | 0.2 | 316 | Citations (PDF) |
| 286 | Randomized comparison of biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents for percutaneous coronary revascularization: Rationale and design of the BIOSCIENCE trial | 2.9 | 16 | Citations (PDF) |
| 287 | The MI SYNTAX score for risk stratification in patients undergoing primary percutaneous coronary intervention for treatment of acute myocardial infarction: A substudy of the COMFORTABLE AMI trial | 2.2 | 27 | Citations (PDF) |
| 288 | Oral or transdermal opioids for osteoarthritis of the knee or hip | 2.1 | 166 | Citations (PDF) |
| 289 | The Impact of Renal Impairment on Long-Term Safety and Effectiveness of Drug-Eluting Stents | 2.3 | 11 | Citations (PDF) |
| 290 | Additive Effect of Anemia and Renal Impairment on Long-Term Outcome after Percutaneous Coronary Intervention | 2.3 | 15 | Citations (PDF) |
| 291 | Will this trial change my practice? ACCOAST - early loading with a novel P2Y12 inhibitor in patients with an acute coronary syndrome | 3.0 | 2 | Citations (PDF) |
| 292 | Tools & Techniques - Statistics: Propensity score techniques | 3.0 | 24 | Citations (PDF) |
| 293 | Intricacies in the analysis and interpretation of optical coherence tomography findings | 3.0 | 8 | Citations (PDF) |
| 294 | Omega-3 Poly-Unsaturated Fatty Acids for the Prevention of Severe Neutropenic Enterocolitis in Patients with Acute Myeloid Leukemia | 2.3 | 9 | Citations (PDF) |
| 295 | Absorbable Collagen Membranes for Periodontal Regeneration | 5.5 | 86 | Citations (PDF) |
| 296 | Combining follow-up and change data is valid in meta-analyses of continuous outcomes: a meta-epidemiological study | 3.7 | 133 | Citations (PDF) |
| 297 | Long-term outcomes of biodegradable polymer versus durable polymer drug-eluting stents in patients with diabetes a pooled analysis of individual patient data from 3 randomized trials | 2.2 | 34 | Citations (PDF) |
| 298 | Comparative efficacy of pharmacological and non-pharmacological interventions in fibromyalgia syndrome: network meta-analysis | 6.9 | 212 | Citations (PDF) |
| 299 | Improved Safety and Reduction in Stent Thrombosis Associated With Biodegradable Polymer-Based Biolimus-Eluting Stents Versus Durable Polymer-Based Sirolimus-Eluting Stents in Patients With Coronary Artery Disease | 3.0 | 318 | Citations (PDF) |
| 300 | A 3-Center Comparison of 1-Year Mortality Outcomes Between Transcatheter Aortic Valve Implantation and Surgical Aortic Valve Replacement on the Basis of Propensity Score Matching Among Intermediate-Risk Surgical Patients | 3.0 | 204 | Citations (PDF) |
| 301 | Percutaneous Closure of Patent Foramen Ovale in Cryptogenic Embolism | 34.5 | 869 | Citations (PDF) |
| 302 | Predictors of functional decline in elderly patients undergoing transcatheter aortic valve implantation (TAVI) | 2.2 | 291 | Citations (PDF) |
| 303 | Clinical outcomes of patients with estimated low or intermediate surgical risk undergoing transcatheter aortic valve implantation | 2.2 | 146 | Citations (PDF) |
| 304 | Comparative Efficacy of Seven Psychotherapeutic Interventions for Patients with Depression: A Network Meta-Analysis | 8.0 | 483 | Citations (PDF) |
| 305 | Do Central Hypersensitivity and Altered Pain Modulation Predict the Course of Chronic Low Back and Neck Pain? | 2.3 | 40 | Citations (PDF) |
| 306 | Ranking of Tests for Pain Hypersensitivity According to Their Discriminative Ability in Chronic Neck Pain | 2.6 | 24 | Citations (PDF) |
| 307 | Atrial Fibrillation and Aortic Stenosis | 4.8 | 126 | Citations (PDF) |
| 308 | Cost-Effectiveness of Percutaneous Coronary Intervention in Patients With Stable Coronary Artery Disease and Abnormal Fractional Flow Reserve | 18.0 | 93 | Citations (PDF) |
| 309 | Patent Foramen Ovale and Cryptogenic Stroke | 34.5 | 16 | Citations (PDF) |
| 310 | Viscosupplementation for Osteoarthritis of the Knee | 9.6 | 5 | Citations (PDF) |
| 311 | Letter regarding “The effects of arthroscopic joint debridement in the knee osteoarthritis: results of a meta‐analysis” | 3.6 | 1 | Citations (PDF) |
| 312 | Antiplatelets versus Anticoagulants for the Treatment of Cervical Artery Dissection: Bayesian Meta-Analysis | 2.3 | 48 | Citations (PDF) |
| 313 | Impact of atrial fibrillation on clinical outcomes among patients with coronary artery disease undergoing revascularisation with drug-eluting stents | 3.0 | 53 | Citations (PDF) |
| 314 | Neue Studienergebnisse zum PFO-Verschluss bei Patienten mit paradoxer Embolie | 0.0 | 0 | Citations (PDF) |
| 315 | Subklinische Hypothyreose | 0.0 | 0 | Citations (PDF) |
| 316 | Effect of Biolimus-Eluting Stents With Biodegradable Polymer vs Bare-Metal Stents on Cardiovascular Events Among Patients With Acute Myocardial Infarction | 16.5 | 286 | Citations (PDF) |
| 317 | Long-Term Propensity Score–Matched Comparison of Percutaneous Closure of Patent Foramen Ovale With Medical Treatment After Paradoxical Embolism | 18.0 | 174 | Citations (PDF) |
| 318 | Serum glucose levels for predicting death in patients admitted to hospital for community acquired pneumonia: prospective cohort study | 0.2 | 126 | Citations (PDF) |
| 319 | ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation | 2.2 | 5,194 | Citations (PDF) |
| 320 | Comparison of drug-eluting stents with bare metal stents in patients with ST-segment elevation myocardial infarction | 2.2 | 137 | Citations (PDF) |
| 321 | Biodegradable polymer drug-eluting stents reduce the risk of stent thrombosis at 4 years in patients undergoing percutaneous coronary intervention: a pooled analysis of individual patient data from the ISAR-TEST 3, ISAR-TEST 4, and LEADERS randomized trials | 2.2 | 373 | Citations (PDF) |
| 322 | Vascular Tissue Reaction to Acute Malapposition in Human Coronary Arteries | 4.8 | 119 | Citations (PDF) |
| 323 | The Impact of Anemia on Long-Term Clinical Outcome in Patients Undergoing Revascularization With the Unrestricted Use of Drug-Eluting Stents | 4.8 | 71 | Citations (PDF) |
| 324 | Predictors of Clinical Outcomes in Patients With Severe Aortic Stenosis Undergoing TAVI | 4.8 | 46 | Citations (PDF) |
| 325 | Methods to convert continuous outcomes into odds ratios of treatment response and numbers needed to treat: meta-epidemiological study | 4.9 | 134 | Citations (PDF) |
| 326 | Clinical Scoring System for Vulvar Lichen Sclerosus | 0.5 | 49 | Citations (PDF) |
| 327 | Doxycycline for osteoarthritis of the knee or hip | 2.1 | 52 | Citations (PDF) |
| 328 | Fractional Flow Reserve–Guided PCI versus Medical Therapy in Stable Coronary Disease | 34.5 | 2,618 | Citations (PDF) |
| 329 | Systolic blood pressure below 110mmHg is associated with increased mortality in penetrating major trauma patients: Multicentre cohort study | 2.8 | 98 | Citations (PDF) |
| 330 | Very Late Coronary Stent Thrombosis of a Newer-Generation Everolimus-Eluting Stent Compared With Early-Generation Drug-Eluting Stents | 18.0 | 366 | Citations (PDF) |
| 331 | Impact of incomplete stent apposition on long-term clinical outcome after drug-eluting stent implantation | 2.2 | 112 | Citations (PDF) |
| 332 | Long-term clinical and angiographic outcomes of diabetic patients after revascularization with early generation drug-eluting stents | 2.9 | 29 | Citations (PDF) |
| 333 | Impact of Permanent Pacemaker Implantation on Clinical Outcome Among Patients Undergoing Transcatheter Aortic Valve Implantation | 2.3 | 206 | Citations (PDF) |
| 334 | Long-Term Comparison of Everolimus- and Sirolimus-Eluting Stents in Patients With Acute Coronary Syndromes | 3.0 | 15 | Citations (PDF) |
| 335 | Impact of Sex on Clinical and Angiographic Outcomes Among Patients Undergoing Revascularization With Drug-Eluting Stents | 3.0 | 67 | Citations (PDF) |
| 336 | Evaluation of Multidimensional Geriatric Assessment as a Predictor of Mortality and Cardiovascular Events After Transcatheter Aortic Valve Implantation | 3.0 | 306 | Citations (PDF) |
| 337 | Long-Term Vascular Healing in Response to Sirolimus- and Paclitaxel-Eluting Stents | 3.0 | 58 | Citations (PDF) |
| 338 | Ranking of parameters of pain hypersensitivity according to their discriminative ability in chronic low back painPain, 2012, 153, 2083-2091 | 4.2 | 84 | Citations (PDF) |
| 339 | Viscosupplementation for Osteoarthritis of the Knee | 9.6 | 558 | Citations (PDF) |
| 340 | Clinical long-term outcome after implantation of titanium nitride-oxide coated stents compared with paclitaxel- or sirolimus-eluting stents: propensity-score matched analysis | 3.0 | 8 | Citations (PDF) |
| 341 | Cerebrovascular accidents complicating transcatheter aortic valve implantation: frequency, timing and impact on outcomes | 3.0 | 111 | Citations (PDF) |
| 342 | Long-Term Comparison of Everolimus-Eluting and Sirolimus-Eluting Stents for Coronary Revascularization | 2.3 | 94 | Citations (PDF) |
| 343 | Clinical Outcomes of Patients With Severe Aortic Stenosis at Increased Surgical Risk According to Treatment Modality | 2.3 | 152 | Citations (PDF) |
| 344 | 2-Year Clinical Follow-Up From the Randomized Comparison of Biolimus-Eluting Stents With Biodegradable Polymer and Sirolimus-Eluting Stents With Durable Polymer in Routine Clinical Practice | 3.0 | 32 | Citations (PDF) |
| 345 | How Valuable are Multiple Treatment Comparison Methods in Evidence-Based Health-Care Evaluation? | 1.9 | 76 | Citations (PDF) |
| 346 | All cause and disease specific mortality in patients with knee or hip osteoarthritis: population based cohort study | 0.1 | 636 | Citations (PDF) |
| 347 | Clinical outcome and predictors for adverse events after transcatheter aortic valve implantation with the use of different devices and access routes | 2.9 | 118 | Citations (PDF) |
| 348 | Long-term tissue coverage of a biodegradable polylactide polymer–coated biolimus-eluting stent: Comparative sequential assessment with optical coherence tomography until complete resorption of the polymer | 2.9 | 45 | Citations (PDF) |
| 349 | Systolic blood pressure below 110mmHg is associated with increased mortality in blunt major trauma patients: Multicentre cohort study | 2.8 | 85 | Citations (PDF) |
| 350 | Long-term clinical outcomes of biodegradable polymer biolimus-eluting stents versus durable polymer sirolimus-eluting stents in patients with coronary artery disease (LEADERS): 4 year follow-up of a randomised non-inferiority trial | 62.1 | 336 | Citations (PDF) |
| 351 | Factor analysis of responses to thermal, electrical, and mechanical painful stimuli supports the importance of multi-modal pain assessmentPain, 2011, 152, 1146-1155 | 4.2 | 125 | Citations (PDF) |
| 352 | Association between cam-type deformities and magnetic resonance imaging-detected structural hip damage: A cross-sectional study in young men | 6.1 | 97 | Citations (PDF) |
| 353 | Sirolimus versus paclitaxel coronary stents in clinical practice | 1.7 | 9 | Citations (PDF) |
| 354 | Comparison of Titanium-Nitride-Oxide–Coated Stents With Zotarolimus-Eluting Stents for Coronary Revascularization | 3.0 | 28 | Citations (PDF) |
| 355 | Multiplicity of data in trial reports and the reliability of meta-analyses: empirical study | 0.1 | 56 | Citations (PDF) |
| 356 | An overview of the objectives of and the approaches to propensity score analyses | 2.2 | 355 | Citations (PDF) |
| 357 | Association of bone attrition with knee pain, stiffness and disability: a cross-sectional study | 6.9 | 16 | Citations (PDF) |
| 358 | Delayed Coverage in Malapposed and Side-Branch Struts With Respect to Well-Apposed Struts in Drug-Eluting Stents | 18.0 | 127 | Citations (PDF) |
| 359 | Value of Age, Creatinine, and Ejection Fraction (ACEF Score) in Assessing Risk in Patients Undergoing Percutaneous Coronary Interventions in the ‘All-Comers' LEADERS Trial | 4.8 | 128 | Citations (PDF) |
| 360 | Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis | 0.1 | 1,017 | Citations (PDF) |
| 361 | The Cochrane Collaboration's tool for assessing risk of bias in randomised trials | 0.1 | 30,272 | Citations (PDF) |
| 362 | Five-Year Clinical and Angiographic Outcomes of a Randomized Comparison of Sirolimus-Eluting and Paclitaxel-Eluting Stents | 18.0 | 177 | Citations (PDF) |
| 363 | Genetic Evidence Supporting the Association of Protease and Protease Inhibitor Genes with Inflammatory Bowel Disease: A Systematic Review | 2.3 | 33 | Citations (PDF) |
| 364 | Implantation of the biodegradable polymer biolimus-eluting stent in patients with high SYNTAX score is associated with decreased cardiac mortality compared to a permanent polymer sirolimus-eluting stent: two year follow-up results from the "Call-comers" LEADERS trial | 3.0 | 22 | Citations (PDF) |
| 365 | Gender inequity in the provision of care for hip disease: population-based cross-sectional study | 5.5 | 50 | Citations (PDF) |
| 366 | The Impact of Body Mass Index on the One Year Outcomes of Patients Treated by Percutaneous Coronary Intervention With Biolimus- and Sirolimus-Eluting Stents (from the LEADERS Trial) | 1.8 | 50 | Citations (PDF) |
| 367 | Acetabular labral tear: do not miss the underlying deformity. Comment on the article by Haroon et al | 2.8 | 0 | Citations (PDF) |
| 368 | Prevalence of cam‐type deformity on hip magnetic resonance imaging in young males: A cross‐sectional study | 2.8 | 175 | Citations (PDF) |
| 369 | Development of a combined database for meta‐epidemiological research | 4.8 | 21 | Citations (PDF) |
| 370 | An optical coherence tomography study of a biodegradable vs. durable polymer-coated limus-eluting stent: a LEADERS trial sub-study | 2.2 | 244 | Citations (PDF) |
| 371 | Small study effects in meta-analyses of osteoarthritis trials: meta-epidemiological study | 0.1 | 522 | Citations (PDF) |
| 372 | Impact of Stent Overlap on Angiographic and Long-Term Clinical Outcome in Patients Undergoing Drug-Eluting Stent Implantation | 2.3 | 159 | Citations (PDF) |
| 373 | Value of the SYNTAX Score for Risk Assessment in the All-Comers Population of the Randomized Multicenter LEADERS (Limus Eluted from A Durable versus ERodable Stent coating) Trial | 2.3 | 205 | Citations (PDF) |
| 374 | Effects of glucosamine, chondroitin, or placebo in patients with osteoarthritis of hip or knee: network meta-analysis | 0.1 | 509 | Citations (PDF) |
| 375 | Sonographic Follow-Up of Patients With Carpal Tunnel Syndrome Undergoing Surgical or Nonsurgical Treatment: Prospective Cohort Study | 1.4 | 70 | Citations (PDF) |
| 376 | Relationship between the logistic EuroSCORE and the Society of Thoracic Surgeons Predicted Risk of Mortality score in patients implanted with the CoreValve ReValving System—A Bern-Rotterdam Study | 2.9 | 155 | Citations (PDF) |
| 377 | Impact of treatment characteristics on response of different breast cancer phenotypes: pooled analysis of the German neo-adjuvant chemotherapy trials | 2.3 | 250 | Citations (PDF) |
| 378 | The twelve-month outcomes of a biolimus eluting stent with a biodegradable polymer compared with a sirolimus eluting stent with a durable polymer | 3.0 | 50 | Citations (PDF) |
| 379 | Authors' reply | 0.1 | 0 | Citations (PDF) |
| 380 | The importance of allocation concealment and patient blinding in osteoarthritis trials: A meta‐epidemiologic study | 5.7 | 134 | Citations (PDF) |
| 381 | The role of correspondence sections in post-publication peer review: A bibliometric study of general and internal medicine journals | 2.4 | 17 | Citations (PDF) |
| 382 | The Effectiveness and Safety of Proton Radiation Therapy for Indications of the Eye | 2.1 | 25 | Citations (PDF) |
| 383 | Impact of Vessel Size on Angiographic and Clinical Outcomes of Revascularization With Biolimus-Eluting Stent With Biodegradable Polymer and Sirolimus-Eluting Stent With Durable Polymer | 3.0 | 49 | Citations (PDF) |
| 384 | Correlation of Intravascular Ultrasound Findings With Histopathological Analysis of Thrombus Aspirates in Patients With Very Late Drug-Eluting Stent Thrombosis | 18.0 | 459 | Citations (PDF) |
| 385 | The effects of excluding patients from the analysis in randomised controlled trials: meta-epidemiological study | 0.1 | 226 | Citations (PDF) |
| 386 | Disagreements in meta-analyses using outcomes measured on continuous or rating scales: observer agreement study | 0.1 | 74 | Citations (PDF) |
| 387 | Meeting report ESC Forum on Drug Eluting Stents, European Heart House, Nice, 27-28 September 2007 | 3.0 | 5 | Citations (PDF) |
| 388 | Reply | 6.1 | 0 | Citations (PDF) |
| 389 | Severe structural damage of the seemingly non-diseased infrarenal aortic aneurysm neck | 1.8 | 31 | Citations (PDF) |
| 390 | Incidence and Correlates of Drug-Eluting Stent Thrombosis in Routine Clinical Practice | 2.3 | 469 | Citations (PDF) |
| 391 | A pain assessment scale for population-based studies: Development and validation of the Pain Module of the Standard Evaluation Questionnaire | 4.2 | 30 | Citations (PDF) |
| 392 | Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (LEADERS): a randomised non-inferiority trial | 62.1 | 627 | Citations (PDF) |
| 393 | Safety of drug-eluting stents | 0.0 | 18 | Citations (PDF) |
| 394 | Meeting Report: ESC Forum on Drug Eluting Stents European Heart House, Nice, 27-28 September 2007 | 2.2 | 34 | Citations (PDF) |
| 395 | Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study | 0.1 | 2,329 | Citations (PDF) |
| 396 | Drug eluting and bare metal stents in people with and without diabetes: collaborative network meta-analysis | 0.1 | 284 | Citations (PDF) |
| 397 | Two-year clinical outcome after implantation of sirolimus-eluting and paclitaxel-eluting stents in diabetic patients | 2.2 | 68 | Citations (PDF) |
| 398 | Preventing Infections in Cancer Patients: Antibiotics, Hematopoetic Growth Factors or Both? a Network AnalysisBlood, 2008, 112, 1315-1315 | 4.8 | 1 | Citations (PDF) |
| 399 | Placebo-controlled trials of Chinese herbal medicine and conventional medicine comparative study | 4.9 | 43 | Citations (PDF) |
| 400 | Accuracy of electrocardiography in diagnosis of left ventricular hypertrophy in arterial hypertension: systematic review | 0.1 | 285 | Citations (PDF) |
| 401 | The characteristics of unsolicited clinical oncology literature provided by pharmaceutical industry | 9.9 | 5 | Citations (PDF) |
| 402 | Bibliographic study showed improving methodology of meta-analyses published in leading journals 1993–2002 | 3.7 | 24 | Citations (PDF) |
| 403 | Matched-pair study showed higher quality of placebo-controlled trials in Western phytotherapy than conventional medicine | 3.7 | 18 | Citations (PDF) |
| 404 | Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study | 62.1 | 1,912 | Citations (PDF) |
| 405 | Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis | 62.1 | 1,364 | Citations (PDF) |
| 406 | Meta-analysis: Chondroitin for Osteoarthritis of the Knee or Hip | 9.6 | 285 | Citations (PDF) |
| 407 | Impact of Vessel Size on Outcome After Implantation of Sirolimus-Eluting and Paclitaxel-Eluting Stents | 2.3 | 76 | Citations (PDF) |
| 408 | A Meta-Analysis of 16 Randomized Trials of Sirolimus-Eluting Stents Versus Paclitaxel-Eluting Stents in Patients With Coronary Artery Disease | 2.3 | 318 | Citations (PDF) |
| 409 | Efficacy and safety of intraarticular hylan or hyaluronic acids for osteoarthritis of the knee: A randomized controlled trial | 6.1 | 132 | Citations (PDF) |
| 410 | Hylan versus hyaluronic acid for osteoarthritis of the knee: A systematic review and meta‐analysis | 5.7 | 167 | Citations (PDF) |
| 411 | Chondroitin for Osteoarthritis of the Knee or Hip | 9.6 | 0 | Citations (PDF) |
| 412 | Glycemic control and macrovascular disease in types 1 and 2 diabetes mellitus: Meta-analysis of randomized trials | 2.9 | 422 | Citations (PDF) |
| 413 | Sleepless night, the moon is bright: longitudinal study of lunar phase and sleep | 3.8 | 57 | Citations (PDF) |
| 414 | Osteoarthritis: rational approach to treating the individual | 3.9 | 214 | Citations (PDF) |
| 415 | Accuracy of B-Type Natriuretic Peptide Tests to Exclude Congestive Heart Failure | 8.1 | 57 | Citations (PDF) |
| 416 | Meta-Analysis: Accuracy of Rapid Tests for Malaria in Travelers Returning from Endemic Areas | 9.6 | 145 | Citations (PDF) |
| 417 | Diagnostic value of sonography in patients with suspected carpal tunnel syndrome: A prospective study | 6.1 | 215 | Citations (PDF) |
| 418 | Assessing bone loss on radiographs of the knee in osteoarthritis: A cross-sectional study | 6.1 | 37 | Citations (PDF) |
| 419 | Consequences of different diagnostic ‘gold standards’ in test accuracy research: Carpal Tunnel Syndrome as an example | 4.9 | 42 | Citations (PDF) |
| 420 | Are the clinical effects of homoeopathy placebo effects? Comparative study of placebo-controlled trials of homoeopathy and allopathy | 62.1 | 777 | Citations (PDF) |
| 421 | Sirolimus-Eluting and Paclitaxel-Eluting Stents for Coronary Revascularization | 34.5 | 554 | Citations (PDF) |
| 422 | Older people should NOT be prescribed 'coxibs' in place of conventional NSAIDs | 1.8 | 17 | Citations (PDF) |
| 423 | Low membrane protein sulfhydrils but not G6PD deficiency predict ribavirin-induced hemolysis in hepatitis C | 10.1 | 31 | Citations (PDF) |
| 424 | Risk of cardiovascular events and rofecoxib: cumulative meta-analysis | 62.1 | 847 | Citations (PDF) |
| 425 | Systematic review of the epidemiologic and trial evidence of an association between antidepressant medication and breast cancer | 3.7 | 53 | Citations (PDF) |
| 426 | Population requirement for primary knee replacement surgery: a cross-sectional study | 2.1 | 87 | Citations (PDF) |
| 427 | Gibt es Gründe für die Gabe von COX-2-Hemmern? | 0.4 | 0 | Citations (PDF) |
| 428 | Systematic review of celecoxib for osteoarthritis and rheumatoid arthritis | 0.1 | 22 | Citations (PDF) |
| 429 | ACUPUNCTURE FOR ALCOHOL WITHDRAWAL: A RANDOMIZED CONTROLLED TRIAL | 1.7 | 38 | Citations (PDF) |
| 430 | Is there a rationale for the use of COX-2 inhibitors? | 0.4 | 0 | Citations (PDF) |
| 431 | Direction and impact of language bias in meta-analyses of controlled trials: empirical study | 4.9 | 832 | Citations (PDF) |
| 432 | Quality of Reporting of Randomized Trials as a Measure of Methodologic Quality | 16.5 | 355 | Citations (PDF) |
| 433 | Clinical epidemiology of osteoarthritis – an introduction | 0.1 | 1 | Citations (PDF) |
| 434 | Statistical methods for assessing the influence of study characteristics on treatment effects in ‘meta-epidemiological’ research | 1.7 | 335 | Citations (PDF) |
| 435 | Systematic reviews in health care: Assessing the quality of controlled clinical trials | 0.1 | 2,885 | Citations (PDF) |
| 436 | Are randomised controlled trials in the
BMJ
different? | 0.1 | 51 | Citations (PDF) |
| 437 | Evidence-based Medicine: Wie beurteilte ich eine Studie zu einer therapeutischen Intervention? | 0.0 | 0 | Citations (PDF) |
| 438 | Evidenced-based Medicine: comment juger une étude d'intervention? | 0.0 | 0 | Citations (PDF) |
| 439 | The Hazards of Scoring the Quality of Clinical Trials for Meta-analysis | 16.5 | 1,767 | Citations (PDF) |
| 440 | Completeness of reporting of trials published in languages other than English: implications for conduct and reporting of systematic reviews | 62.1 | 521 | Citations (PDF) |
| 441 | S-Adenosylmethionine for osteoarthritis of the knee or hip | 2.1 | 56 | Citations (PDF) |
| 442 | Transcutaneous electrostimulation for osteoarthritis of the knee | 2.1 | 181 | Citations (PDF) |
| 443 | Joint lavage for osteoarthritis of the knee | 2.1 | 80 | Citations (PDF) |
| 444 | Therapeutic ultrasound for osteoarthritis of the knee or hip | 2.1 | 143 | Citations (PDF) |
| 445 | ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions | 0.2 | 15,686 | Citations (PDF) |
| 446 | Bivalirudin or unfractionated heparin in patients with acute coronary syndromes managed invasively with and without ST elevation (MATRIX): randomised controlled trial | 0.2 | 49 | Citations (PDF) |
| 447 | Symptomatic treatment of uncomplicated lower urinary tract infections in the ambulatory setting: randomised, double blind trial | 0.1 | 129 | Citations (PDF) |
| 448 | Outcomes of non-invasive diagnostic modalities for the detection of coronary artery disease: network meta-analysis of diagnostic randomised controlled trials | 0.1 | 110 | Citations (PDF) |
| 449 | RoB 2: a revised tool for assessing risk of bias in randomised trials | 0.1 | 25,130 | Citations (PDF) |
| 450 | Tramadol for osteoarthritis | 2.1 | 46 | Citations (PDF) |
| 451 | P2Y12 inhibitor monotherapy or dual antiplatelet therapy after coronary revascularisation: individual patient level meta-analysis of randomised controlled trials | 0.2 | 207 | Citations (PDF) |
| 452 | Effectiveness of therapeutic heparin versus prophylactic heparin on death, mechanical ventilation, or intensive care unit admission in moderately ill patients with covid-19 admitted to hospital: RAPID randomised clinical trial | 0.2 | 297 | Citations (PDF) |
| 453 | Effectiveness and safety of non-steroidal anti-inflammatory drugs and opioid treatment for knee and hip osteoarthritis: network meta-analysis | 0.2 | 280 | Citations (PDF) |
| 454 | Viscosupplementation for knee osteoarthritis: systematic review and meta-analysis | 0.2 | 124 | Citations (PDF) |
| 455 | Reply to comment on "Effectiveness and safety of intra-articular interventions for knee and hip osteoarthritis based on large randomized trials: A systematic review and network meta-analysis" | 5.5 | 1 | Citations (PDF) |
| 456 | The authors respond | 0.1 | 0 | Citations (PDF) |
| 457 | Transcatheter Treatment of Bicuspid Aortic Valve Stenosis: From Observational Studies to Randomized Clinical Trials | 1.6 | 3 | Citations (PDF) |
| 458 | Fractional flow reserve-guided percutaneous coronary intervention versus medical therapy for stable coronary artery disease: long-term results of the FAME 2 trial | 33.0 | 6 | Citations (PDF) |
| 459 | 2024 revision of ESC levels of evidence: stopping randomized trials too early may prevent changes in clinical practice | 2.2 | 0 | Citations (PDF) |
